SETV.W

SETV.W is addressing the critical challenge of improving oncological outcomes by providing precise, personalized, and proactive healthcare solutions through the integration of Artificial Intelligence (AI) and Machine Learning (ML). The problem is pervasive and significant, both in the communities we serve and globally, as cancer remains a leading cause of death and a major barrier to increasing life expectancy.

The scale of the Problem:

Globally, cancer is the second leading cause of death, responsible for an estimated 9.6 million deaths, or one in six deaths, in 2018, according to the World Health Organization (WHO). In the communities we work in, the burden of cancer is exacerbated by disparities in access to care, late-stage presentation, and diagnosis, which are common issues in low- and middle-income countries where nearly 70% of cancer deaths occur.

The scale of the problem is highlighted by the fact that the global cancer burden is expected to grow to 27.5 million new cancer cases by 2040 due to the growth and ageing of the population alone, as per the International Agency for Research on Cancer (IARC). This does not even take into account the potential increase due to factors like smoking, poor diet, physical inactivity, and pollution, among others.

Factors Contributing to the Problem:

Several key factors contribute to the oncology care challenge that SETV.W's solution addresses:

1. Late Detection: Many cancers are detected at a late stage, reducing the chances of survival. Early detection is crucial in improving cancer outcomes and survival rates.
2. Inadequate Personalization: Cancer treatment often follows a 'one-size-fits-all' approach, despite the disease varying significantly between individuals.
3. Limited Access: In many regions, there is limited access to advanced diagnostic tools and treatments, which leads to poorer health outcomes.
4. Data Fragmentation: Healthcare data is often fragmented and siloed, hindering effective analysis and insights that could inform treatment plans.

SETV.W’s platform is a synergistic fusion of AI insights and healthcare expertise tailored to advance oncological care. Our solution is distinctively architected to enhance decision-making in treatment strategies and patient care pathways, distinguishing itself by offering a unique, comprehensive service that goes beyond the capabilities of other solutions in the market.

Here's a breakdown of SETV.W’s offering:

• Integrated Health Intelligence: By synthesizing data from a broad spectrum of health parameters, SETV.W provides a multi-dimensional view of patient health, enabling a deeper understanding of each patient's unique healthcare journey.
• Adaptive Health Navigation: SETV.W guides patients through the complex landscape of healthcare options with adaptive pathways that are responsive to each patient's evolving needs, a service that sets it apart in its dedication to patient-centric care.
• Proactive Health Mapping: Leveraging predictive analytics, SETV.W anticipates health trajectories, offering a forward-thinking approach to healthcare that focuses on prevention and early intervention.
• Operational Harmonization: SETV.W streamlines clinical workflows, ensuring that care providers can focus more on patient interaction and less on administrative tasks, thus fostering a more humane and engaging healthcare experience.

How SETV.W Works:

SETV.W operates on a cloud-based infrastructure that seamlessly integrates with current healthcare systems, ensuring accessibility and scalability. Our platform's AI algorithms are designed to be ethical and inclusive, trained on diverse datasets to provide equitable and precise healthcare insights. Through the secure processing of health data, SETV.W generates actionable recommendations while upholding the highest standards of data privacy and security.

In practice, SETV.W’s services materialize as a background force that empowers doctors with a data-informed second opinion, aids patients in navigating their health choices, and assists administrators in managing healthcare delivery with enhanced efficiency.

Our Distinct Edge:

SETV.W is uniquely positioned due to its commitment to advancing healthcare with AI that is as compassionate as it is intelligent. Our platform is not just about the technology, it's about how the technology is an extension of our ethos to care and support—making healthcare more human and personalized.

@SETV.W we are dedicated to serving a diverse population that includes individuals at risk for, or battling cancer, healthcare practitioners seeking to optimize patient care, and healthcare systems looking to enhance efficiency and outcomes.

Our target population primarily encompasses those who face barriers to accessing personalized and predictive healthcare. These are often individuals in remote or underserved regions, where current healthcare systems may not provide the comprehensive and personalized care required for complex conditions like cancer. They may also include populations that are at a higher risk due to genetic predispositions or environmental factors but lack the means for early detection and preventive care.

This group is currently underserved in several ways:

• Lack of Access: Limited access to advanced diagnostic tools and specialized care, particularly in low-resource settings.
• Delayed Diagnosis: A higher likelihood of late-stage cancer diagnosis, which significantly impacts treatment effectiveness and survival rates.
• Information Gap: Insufficient personalized health information to make informed decisions about their healthcare journey.

SETV.W addresses these needs through the following impacts:

1. Early and Accurate Diagnosis: By providing healthcare practitioners with AI-driven diagnostic tools, patients benefit from early detection of cancer, which is critical for successful treatment and improved survival rates.
2. Personalized Treatment: Our platform’s predictive analytics facilitate personalized treatment plans, increasing the chances of successful outcomes by considering the patient's unique health profile, including genetic factors.
3. Empowerment Through Information: Patients gain access to information and insights about their health, empowering them with the knowledge to actively participate in their healthcare decisions.
4. Improved Access to Care: By delivering our services through a cloud-based platform, we extend the reach of advanced oncological care to remote and underserved regions, democratizing access to healthcare innovations.
5. Efficient Care Coordination: Healthcare systems benefit from improved operational efficiency, enabling them to focus resources on patient care rather than administrative tasks.

In essence, SETV.W's solution is about providing hope and actionable pathways for individuals who might otherwise face a passive healthcare experience. We aim to transform their journey into one where they have active agency—supported by a system that anticipates their needs, understands their health narratives, and offers optimized care pathways, tailored to their specific contexts.

Our commitment to developing SETV.W is deeply personal and driven by a genuine desire to ensure no family endures the hardships ours did due to late diagnosis and inaccessible treatment options for cancer. The impetus behind our mission stems from witnessing firsthand the challenges, emotional turmoil, and often devastating outcomes associated with delayed and impersonal healthcare responses. This personal connection to the problem instils in us a profound sense of responsibility and an unwavering commitment to our mission.

Proximity to the Community:

The core of our team, including the Team Lead, shares a common bond—each of us has been touched by the struggle against cancer through close family members. This shared experience has not only provided us with an intimate understanding of the patient and family journey through diagnosis, treatment, and the often tumultuous path to recovery but has also fueled our determination to create a solution that addresses the critical gaps in the current healthcare system.

Our personal experiences have allowed us to empathize deeply with the communities we aim to serve. They're not just the target population for us, they are reflections of our own journeys. This connection ensures that our solution is not just technologically advanced but is also compassionate, patient-centered, and tailored to meet the real and nuanced needs of those at risk or battling cancer.

Guided by Community Input:

The design and implementation of SETV.W are deeply rooted in community engagement. We believe that meaningful innovation can only emerge from an ongoing dialogue with those we aim to serve. To this end, we plan to establish advisory groups consisting of patients, survivors, family members, healthcare professionals, and researchers. These groups provide continuous feedback, guiding the development of our platform to ensure it is responsive to the actual needs, preferences, and challenges of the community.

Moreover, we are committed to incorporating the community's ideas and agendas into our solution. This includes prioritizing user-friendly interfaces to accommodate varying levels of tech literacy, ensuring our predictive models are inclusive and representative of diverse demographics, and addressing the specific concerns and suggestions raised by community members during our development process.

Conclusion:

Our team's unique positioning to deliver SETV.W lies in our profound personal connection to the mission, our representative composition of the communities we aim to serve, and our commitment to community-driven innovation. This blend of personal experience, empathy, and engagement ensures that SETV.W is more than just a technological solution—it is a heartfelt response to a challenge we intimately understand. Our goal is to ensure that through SETV.W, no individual or family feels alone or powerless in their health journey, making our solution not just innovative but imbued with hope, compassion, and a deep sense of purpose.

SETV.W has developed and tested a prototype leveraging existing resources, data usage permissions from various organizations, and in-house development efforts, all for $0. This frugal innovation approach has allowed us to create a functional prototype focused on harnessing AI for improved oncology care.

What We've Built and Tested:

Our prototype includes an AI-driven platform capable of analyzing patient data to offer predictive insights and personalized healthcare recommendations. The development was guided by permissions for data usage graciously granted by partner organizations, enabling us to train our algorithms on diverse and comprehensive datasets. This has been critical in ensuring our solution is robust, inclusive, and sensitive to a wide array of patient needs and conditions.

The technological backbone of our prototype includes AI models trained to interpret medical data, identify patterns indicative of oncological diseases, and suggest possible interventions. This is complemented by a user-friendly interface designed to facilitate easy interaction for healthcare providers and patients alike.

The prototype as of now has achieved an accuracy of about 93% which is about 20-25 correct outputs out of 30 inputs. This accuracy is also made in a way that it is possible to increase by just increasing the data availability.

Our application to Solve is driven by a multifaceted vision to surmount the financial, technical, legal, and market barriers that currently hinder our progress, with the overarching goal of bringing our AI-driven oncology care platform, SETV.W, to its full potential and scaling its impact globally.

Financial Capital:

While our prototype development has been achieved with minimal costs, scaling our solution requires significant financial resources. We aim to enhance our AI models, expand our data capabilities, and ensure our platform’s robustness and security. Financial support is crucial for these next steps, but equally, we seek strategic partnerships that offer more than just capital. We believe Solve can connect us with partners who provide funding coupled with valuable industry insights, helping us to smartly allocate resources where they can have the greatest impact.

Legal Compliance:

Navigating the complex landscape of healthcare regulation and data protection laws is a significant challenge, especially as we aim to expand globally. Compliance with HIPAA in the U.S., GDPR in Europe, and other local regulations is critical to operate effectively and ethically. We hope Solve can help us access legal expertise and mentorship, guiding us through the necessary compliance processes and ensuring our platform meets all regulatory standards while still innovating at the edge of healthcare technology.

Technical Advancement and Mentorship:

While our team has achieved remarkable milestones with our prototype, advancing our technology to ensure scalability, reliability, and user engagement requires further expertise. Mentorship from industry leaders in AI, healthcare technology, and platform development, which we hope to access through Solve, will be invaluable. This mentorship can help us refine our technical strategy, adopt best practices in software development and AI application, and ultimately create a more effective and user-friendly platform.

Global Expansion:

To create value for a wide range of people globally, especially in underserved communities, we need to tailor our solution to diverse healthcare environments and patient needs. This requires a deep understanding of various cultural contexts and market dynamics. Through Solve, we aim to connect with a global network of healthcare professionals, researchers, and entrepreneurs who can provide insights into local healthcare challenges, preferences, and opportunities for innovation. This knowledge exchange will be crucial in adapting and scaling our solution across different regions.

In conclusion, our application to Solve is motivated by the desire to leverage the program's network, expertise, and resources to overcome the barriers we face. By joining the Solve community, we aim not just to advance SETV.W as a product but to build our company into a global force for good in the healthcare sector, delivering personalized, predictive, and accessible cancer care to those who need it most.

SETV.W distinguishes itself through an innovative approach that integrates cutting-edge Artificial Intelligence (AI) and Machine Learning (ML) directly into the fabric of oncology care. Our solution departs from traditional methods by leveraging a holistic, data-driven strategy that personalizes and enhances the cancer care continuum—from prevention and early detection to treatment and follow-up care. This innovation is not merely an incremental improvement, it represents a paradigm shift in how oncology care can be delivered and experienced.

Innovative Aspects of SETV.W:

1. Personalized Care at Scale: SETV.W utilizes AI and ML to analyze vast arrays of medical data, including genetic information, to tailor care plans to the individual’s unique health profile. This level of personalization at scale is unprecedented in traditional healthcare settings and has the potential to significantly improve treatment outcomes.
2. Predictive Health Insights: Our platform anticipates health risks by identifying patterns and anomalies in patient data that may not be evident to human practitioners. This predictive capability can transform oncology care from reactive to proactive, catching potential issues before they become life-threatening.
3. Streamlining Healthcare Management: Beyond direct patient care, SETV.W optimizes the operational aspects of healthcare delivery. By automating administrative tasks and integrating seamlessly with existing healthcare systems, it allows healthcare providers to devote more time to patient care and less to paperwork.
4. Democratizing Access to Oncology Care: By offering our platform through a cloud-based service, we aim to make advanced oncology care accessible even in remote or underserved regions. This approach has the potential to bridge the gap in healthcare disparities, making high-quality cancer care a reality for all.

Catalyzing Broader Positive Impacts:

SETV.W’s innovative approach can serve as a model for leveraging technology to address complex healthcare challenges. By demonstrating the viability and effectiveness of AI-driven personalized care, it can encourage further investments and innovation in healthcare technology. This, in turn, can accelerate the development of new solutions that cater to various aspects of health and wellness, beyond oncology.

Changing the Market/Landscape:

SETV.W has the potential to redefine the expectations and standards for oncology care. By proving that personalized, predictive, and efficient care is achievable, it could push the entire healthcare industry towards more patient-centered and technology-driven models. This shift could stimulate competition and innovation within the healthcare technology sector, leading to a broad range of improved healthcare solutions.

Furthermore, SETV.W's emphasis on accessibility and scalability challenges the market to think globally and inclusively, prioritizing solutions that address healthcare disparities. As SETV.W demonstrates the tangible benefits of such an approach, it could inspire a market-wide transformation towards more equitable healthcare technologies.

In summary, SETV.W's innovative solution not only addresses the immediate challenges of oncology care but also has the potential to catalyze a shift in the healthcare landscape towards more personalized, predictive, and equitable care for all.

Theory of Change for SETV.W

Our Mission:

To revolutionize oncology care through AI-driven innovations, making cancer treatment more personalized, predictive, and accessible, thereby significantly improving patient outcomes.

Activities:

1. Develop AI and ML Models: Utilize advanced algorithms to analyze medical data for personalized treatment plans and predictive health insights.
2. Implement Cloud-Based Platform: Offer our services through a scalable, accessible cloud-based system to ensure wide-reaching impact.
3. Engage with Communities: Collaborate with healthcare professionals, patients, and institutions to refine and adapt our solution to meet diverse needs.
4. Ensure Compliance and Data Security: Rigorously uphold privacy standards and regulatory compliance to protect patient information.

Outputs:

1. Enhanced Diagnostic Accuracy: AI models trained on diverse datasets provide more accurate, early detection of oncological conditions.
2. Personalized Treatment Recommendations: Data-driven insights enable tailored treatment plans, improving efficacy and reducing side effects.
3. Increased Access to Oncology Care: Cloud-based delivery democratizes access to cutting-edge healthcare services, especially in underserved regions.
4. Streamlined Healthcare Operations: Automated administrative tasks allow healthcare providers to focus more on patient care.

Short-term Outcomes:

1. Improved Patient Engagement: Patients become more involved in their care process through personalized insights and recommendations.
2. Reduced Diagnostic Delays: Early and accurate detection leads to timely interventions, preventing disease progression.
3. Enhanced Treatment Outcomes: Tailored treatment strategies result in better response rates and fewer complications.
4. Increased Healthcare Efficiency: Reduced administrative burden and enhanced decision-making streamline operations.

Long-term Outcomes:

1. Decreased Mortality Rates: Early detection and personalized treatment significantly lower cancer mortality rates.
2. Improved Quality of Life: Patients experience better health outcomes, less distress from side effects, and increased satisfaction with their care.
3. Healthcare System Sustainability: Efficient resource utilization and effective treatments reduce overall healthcare costs.
4. Global Health Equity: Bridging access gaps contributes to more equitable health outcomes worldwide.

Evidence to Support Links:

• Research on AI Diagnostics: Studies, such as those published in Nature Medicine, have shown AI's capability to match or exceed specialist performance in diagnosing diseases like cancer.
• Data on Personalized Medicine: Research by the Personalized Medicine Coalition illustrates the effectiveness of tailored treatments in improving patient outcomes and reducing healthcare costs.
• Pilot Feedback: Initial testing with healthcare professionals and patients has shown positive responses to usability and the perceived value of SETV.W’s insights.
• Global Health Disparities Research: WHO reports and data underscore the critical need for accessible healthcare innovations to address global disparities.

Conclusion:

SETV.W's approach to integrating AI into oncology care embodies a clear, evidence-backed pathway from innovative activities to transformative long-term outcomes. By aligning cutting-edge technology with the pressing needs of patients and healthcare systems, SETV.W not only aims to improve cancer care but also to contribute to a more equitable global healthcare landscape.

Impact Goals for SETV.W:

1. Improve Early Cancer Detection Rates: By leveraging AI, our goal is to enhance the accuracy and timeliness of cancer diagnoses, aiming for a 40% improvement in early detection rates within the first three years of implementation.

2. Personalize Treatment Plans to Increase Efficacy: Utilizing data-driven insights, we strive to tailor treatment plans for at least 70% of our patient base, reducing the one-size-fits-all approach and enhancing treatment outcomes.

3. Democratize Access to Oncology Care: Expand our services to underserved communities, aiming to increase access to oncology care by 50% in targeted regions within five years.

4. Enhance Healthcare Efficiency: Streamline healthcare operations to reduce administrative time by 30% for healthcare providers using our platform, allowing them more time for patient care.

Measuring Progress:

To track our progress towards these goals, we have established specific indicators:

1. Early Detection Rate Increase:

   • Indicator: The percentage increase in cancers diagnosed at stage I or II after the adoption of SETV.W.
   • Data Source: Hospital and clinic records before and after SETV.W implementation.

2. Personalization of Treatment Plans:

   • Indicator: The proportion of patients receiving personalized treatment recommendations based on their genetic profile or specific health data.
   • Data Source: User data analytics from the SETV.W platform.

3. Increased Access in Underserved Communities:

   • Indicator: The number of new users from targeted underserved regions or communities.
   • Data Source: User registration data with geographic tagging.

4. Reduced Administrative Time for Healthcare Providers:

   • Indicator: The average reduction in hours spent on administrative tasks by healthcare providers using SETV.W.
   • Data Source: Surveys and time-tracking studies among healthcare providers before and after SETV.W adoption.

Supporting Indicators from UN SDGs:

Aligned with the United Nations Sustainable Development Goals (SDGs), particularly Goal 3: Good Health and Well-Being, we also consider:

• SDG Indicator 3.4.1: Mortality rate attributed to cardiovascular disease, cancer, diabetes, or chronic respiratory disease.
• SDG Indicator 3.8.1: Coverage of essential health services (including access to cancer care).

Conclusion:

Our commitment to these impact goals and the rigorous measurement of our progress is central to SETV.W’s mission. By closely monitoring these indicators, not only can we assess our impact on improving oncology care but also contribute to broader health and well-being outcomes on a global scale. The transformative potential of SETV.W lies in its ability to leverage AI for significant advancements in cancer care, reflected in the lives saved, the quality of life improved, and the healthcare systems made more efficient and accessible.

Impact Goals for SETV.W:

1. Improve Early Cancer Detection Rates: By leveraging AI, our goal is to enhance the accuracy and timeliness of cancer diagnoses, aiming for a 40% improvement in early detection rates within the first three years of implementation.

2. Personalize Treatment Plans to Increase Efficacy: Utilizing data-driven insights, we strive to tailor treatment plans for at least 70% of our patient base, reducing the one-size-fits-all approach and enhancing treatment outcomes.

3. Democratize Access to Oncology Care: Expand our services to underserved communities, aiming to increase access to oncology care by 50% in targeted regions within five years.

4. Enhance Healthcare Efficiency: Streamline healthcare operations to reduce administrative time by 30% for healthcare providers using our platform, allowing them more time for patient care.

Measuring Progress:

To track our progress towards these goals, we have established specific indicators:

1. Early Detection Rate Increase:

   • Indicator: The percentage increase in cancers diagnosed at stage I or II after the adoption of SETV.W.
   • Data Source: Hospital and clinic records before and after SETV.W implementation.

2. Personalization of Treatment Plans:

   • Indicator: The proportion of patients receiving personalized treatment recommendations based on their genetic profile or specific health data.
   • Data Source: User data analytics from the SETV.W platform.

3. Increased Access in Underserved Communities:

   • Indicator: The number of new users from targeted underserved regions or communities.
   • Data Source: User registration data with geographic tagging.

4. Reduced Administrative Time for Healthcare Providers:

   • Indicator: The average reduction in hours spent on administrative tasks by healthcare providers using SETV.W.
   • Data Source: Surveys and time-tracking studies among healthcare providers before and after SETV.W adoption.

Supporting Indicators from UN SDGs:

Aligned with the United Nations Sustainable Development Goals (SDGs), particularly Goal 3: Good Health and Well-Being, we also consider:

• SDG Indicator 3.4.1: Mortality rate attributed to cardiovascular disease, cancer, diabetes, or chronic respiratory disease.
• SDG Indicator 3.8.1: Coverage of essential health services (including access to cancer care).

Conclusion:

Our commitment to these impact goals and the rigorous measurement of our progress is central to SETV.W’s mission. By closely monitoring these indicators, not only can we assess our impact on improving oncology care but also contribute to broader health and well-being outcomes on a global scale. The transformative potential of SETV.W lies in its ability to leverage AI for significant advancements in cancer care, reflected in the lives saved, the quality of life improved, and the healthcare systems made more efficient and accessible.

Our company consists of 10 people currently in the AI field who are developing this product. 

3 are full time and the rest 7 are part time.

In the overall oncology field (including AI) we have a team of about 14 people

where 7 are full time and the rest 7 ae part time.

We have been working on this product for 7 months only for development and prior to that we took 3 months for ideation, validation and business evaluation.

In the beginning, it was only a single person and then after four months we onboarded 4 people and currently, we have 10 people in the whole AI development team who are building this solution.

At SETV, we believe our strength lies in our diversity, driving innovation and empathy in our approach to healthcare solutions. Our leadership team encompasses a range of cultural, gender, and professional backgrounds, reflecting the global community we serve. We are committed to fostering an environment where every team member feels valued, heard, and empowered to contribute their unique perspectives and skills.

Actions and Goals:

• Recruitment and Retention: We prioritize diversity in our hiring processes and actively seek candidates from underrepresented groups in tech and healthcare. Our retention strategies include mentorship programs, career development opportunities, and a supportive work culture that recognizes and celebrates individual contributions and achievements.
• Education and Awareness: Regular workshops and training sessions on diversity, equity, and inclusion (DEI) principles are mandatory for all team members, ensuring awareness and understanding of the importance of an inclusive environment.
• Equitable Opportunities: We are dedicated to creating equitable access to opportunities within SETV, ensuring that advancement and development opportunities are based on merit and contributions, not background or identity.
• Feedback and Improvement: An open-door policy for feedback on our DEI efforts helps us continuously improve. We regularly review our policies and practices to identify and eliminate barriers to inclusion and equity.

Our goal is to ensure that SETV not only advances healthcare through technology but also leads by example in creating a diverse, equitable, and inclusive workplace where everyone can thrive.

SETV.W operates on a hybrid business model that combines social impact with sustainability, focusing on improving oncology care through AI-driven solutions. Our model is designed to address the critical need for personalized, efficient, and accessible cancer treatment and healthcare management.

Key Customers and Beneficiaries:

Our primary customers include healthcare institutions (hospitals, clinics), oncology professionals, and research organizations. The direct beneficiaries of our solutions are patients facing oncological challenges, particularly those in underserved communities with limited access to specialized care.

Products and Services:

1. AI-Powered Diagnostic Tools: Utilizing advanced algorithms for early detection and accurate diagnosis of oncological diseases.
2. Personalized Treatment Recommendations: Offering predictive analytics to tailor treatment plans to individual patient profiles, improving outcomes.
3. Healthcare Management Platform: Streamlining administrative processes for healthcare providers, enhancing operational efficiency and patient care.

Delivery Method:

Our products and services are delivered through a cloud-based platform, ensuring scalability and accessibility. This approach allows us to reach a global audience, particularly targeting regions where oncological care is most needed.

Value Proposition:

• For Healthcare Providers: Our solutions improve diagnostic accuracy, personalize patient care, and optimize operations, leading to better outcomes and increased efficiency.
• For Patients: We provide access to cutting-edge care, empowering them with information and options for their treatment journey, regardless of their geographical location.

Revenue Streams:

1. Subscription Model: Healthcare institutions subscribe to our platform for ongoing access to our diagnostic and management tools.
2. Pay-per-Use: Offering specific services, like personalized treatment recommendations, on a pay-per-use basis for smaller clinics or independent professionals.
3. Data Analysis Services: Providing research organizations with anonymized data insights to support oncological studies and drug development, ensuring compliance with all privacy regulations.

Sustainability and Impact:

Our business model is designed to be both sustainable and impactful. By aligning our revenue generation with our mission to democratize oncology care, we ensure that our growth directly contributes to wider access to high-quality care. We continuously reinvest a portion of our profits into research and development, improving our offerings and expanding our reach to underserved populations.

In summary, SETV.W's business model not only addresses the urgent need for innovation in oncology care but also ensures the sustainability and scalability of our solutions, enabling us to make a lasting impact on the global healthcare landscape.

SETV.W’s strategy for achieving financial sustainability is multifaceted, incorporating a mix of revenue streams that leverage our innovative AI-driven oncology care solutions. Our model is designed to ensure long-term viability while maximizing our impact on improving cancer care globally.

Revenue Streams:

1. Subscription Services: We offer subscription-based access to our AI diagnostic tools and healthcare management platform to hospitals, clinics, and healthcare providers. This recurring revenue model provides a stable income stream, allowing for continuous improvement and scaling of our services.
2. Pay-per-Use Services: For healthcare providers requiring less frequent access to our advanced diagnostic tools, we provide a pay-per-use option. This flexibility helps us cater to a wider range of users, from large hospitals to independent practitioners.
3. Data Analysis and Research Services: We collaborate with pharmaceutical companies and research institutions, offering them insights derived from anonymized patient data to aid in drug development and oncological research. This not only generates revenue but also contributes to the broader field of cancer research.
4. Grants and Donations: We actively seek grants and donations from organizations aligned with our mission. These funds are primarily used for research and development and to subsidize access for healthcare providers in underserved regions.
5. Investment Capital: To fuel our initial growth and development, we will raise capital from investors who share our vision for revolutionizing oncology care in either series or pre revenue investment as our company is currently completely bootstrapped. These funds support our operational expenses, research and development, and market expansion.